title: Prolactin serum concentrations after electroconvulsive therapy in a depressed patient with cabergoline-treated prolactinoma: implications for treatment.
authors.affiliation: Department of Psychiatry and Psychotherapy III and Department of Neurology, University of Ulm, Ulm, Germany emily.feneberg@uni-ulm.de Department of Psychiatry and Psychotherapy III, University of Ulm, Ulm, Germany Department of Internal Medicine I, University of Ulm, Ulm, Germany Department of Neuroradiology, BKH-Günzburg, University of Ulm, Günzburg, Germany Department of Psychiatry and Psychotherapy III, University of Ulm, Ulm, Germany.
authors.forename: Emily
authors.initials: E
authors.lastname: Feneberg
authors.forename: Maximilian
authors.initials: M
authors.lastname: Gahr
authors.forename: Eik
authors.initials: E
authors.lastname: Baumgarten
authors.forename: Bernhard
authors.initials: B
authors.lastname: Connemann
authors.forename: Sigrun
authors.initials: S
authors.lastname: Merger
authors.forename: Yigit
authors.initials: Y
authors.lastname: Özpeynirci
authors.forename: Carlos
authors.initials: C
authors.lastname: Schönfeldt-Lecuona
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077465:Cabergoline; D003865:Major Depressive Disorder / Q000097:blood* / Q000150:complications* / Q000628:therapy; D004565:Electroconvulsive Therapy / Q000009:adverse effects*; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000097:blood* / Q000150:complications* / Q000188:drug therapy; D011388:Prolactin / Q000097:blood*; D015175:Prolactinoma / Q000097:blood* / Q000150:complications* / Q000188:drug therapy
chemical_list: D000928:Antidepressive Agents; D000970:Antineoplastic Agents; D004873:Ergolines; D011388:Prolactin; D000077465:Cabergoline